Imperva, Inc.
IMPV
IMPV was delisted on the 9th of January, 2019.
0 hedge funds and large institutions have $0 invested in Imperva, Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 161 closing their positions.
100% less funds holding
Funds holding: 162 → 0 (-162)
100% less funds holding in top 10
Funds holding in top 10: 11 → 0 (-11)
100% less capital invested
Capital invested by funds: $1.87B → $0 (-$1.87B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 161
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
Eminence Capital
New York
|
-$175M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$172M |
| 3 |
BlackRock
New York
|
-$136M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$91.8M |
| 5 |
Goldman Sachs
New York
|
-$89.3M |
IMPV Hedge Fund Activity: Q1 2019 in Review
0 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Imperva, Inc. (IMPV) for Q1 2019, worth a combined $0 — down 100% from $1.87B a quarter earlier.
Sellers outnumbered buyers: 161 funds closed out of IMPV and 0 opened new positions — a net loss of 161 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Eminence Capital, exiting entirely with an estimated $175M sold.
- 0 institutional investors held Imperva, Inc. (IMPV) as of Q1 2019, down from 162 in Q4 2018.
- Funds reported $0 of Imperva, Inc. stock for Q1 2019, down 100% quarter-over-quarter.
- 0 funds opened new Imperva, Inc. positions in Q1 2019 and 161 closed out, a net change of -161 holders.
- The largest Imperva, Inc. seller in Q1 2019 was Eminence Capital, an estimated $175M sold.
Based on aggregated 13F filings for Q1 2019.